B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis-Reference-Cited by-同舟云学术

B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis

Published:2014-12-28 Issue:3 Volume:45 Page:705-715
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Brühl Hilke¹,Cihak Josef²,Talke Yvonne³,Gomez Manuel Rodriguez³,Hermann Fabian³,Goebel Nicole³,Renner Kerstin³,Plachý Jiří⁴,Stangassinger Manfred²,Aschermann Susanne⁵,Nimmerjahn Falk⁵,Mack Matthias³

Affiliation:

1. Department of Internal Medicine I; University Hospital Regensburg; Regensburg Germany

2. Institute for Animal Physiology; University of Munich; Munich Germany

3. Department of Internal Medicine II; University Hospital Regensburg; Regensburg Germany

4. Institute of Molecular Genetics; Czech Academy of Sciences; Prague Czech Republic

5. Institute of Genetics; University of Erlangen-Nuernberg; Erlangen Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum.,2006

2. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N. Engl. J. Med.,2004

3. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis;Jones;N. Engl. J. Med.,2010

4. Rituximab versus cyclophosphamide for ANCA-associated vasculitis;Stone;N. Engl. J. Med.,2010

5. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE));Emery;Ann. Rheum. Dis.,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer;European Journal of Immunology;2023-10-20

2. Multi-targeted immunotherapeutics to treat B cell malignancies;Journal of Controlled Release;2023-06

3. Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model;The Journal of Immunology;2022-04-01

4. B‐cell modulation with anti‐CD79b antibodies ameliorates experimental autoimmune encephalitis in mice;European Journal of Immunology;2022-01-11

5. Nanomedicines in B cell-targeting therapies;Acta Biomaterialia;2022-01